Scilex Holding Company — Form 8-K Summary
Business Context and Reporting Period
Filed June 1, 2023, under Item 2.02 to report preliminary unaudited ZTlido sales results for May 2023 and the year-to-date period ended May 31, 2023. The data was prepared by management, has not been reviewed or audited by the independent auditor, and remains subject to revision.
Key Financial and Operating Metrics
| Metric | May 2023 | May 2022 | Change |
|---|---|---|---|
| ZTlido gross sales | $13.0 million–$15.0 million | $8.5 million | 53%–76% growth |
| ZTlido net sales | $4.2 million–$5.1 million | $2.8 million | 50%–82% growth |
| Metric | Year-to-date May 2023 | Year-to-date May 2022 | Change |
|---|---|---|---|
| ZTlido gross sales | $49.2 million–$54.3 million | $32.0 million | 54%–70% growth |
| ZTlido net sales | $16.0 million–$19.0 million | $11.4 million | 40%–67% growth |
The filing does not provide current-period figures for net income, operating income, cash flow, margins, debt, cash, liquidity, or earnings per share.
Material Changes Versus the Prior Comparable Period
- Estimated ZTlido gross sales and net sales increased substantially in May 2023 and year to date compared with the corresponding 2022 periods.
- The filing reports ranges rather than finalized results, so the exact magnitude of growth remains uncertain.
Outlook, Commentary, Risks, and Unusual Items
- Management provided preliminary estimates only; actual results may differ materially and may fall outside the stated ranges.
- The company had not completed its review of the May 2023 and year-to-date preliminary financial results as of the filing date.
- The reported information is not deemed “filed” for purposes of Section 18 liability and is not incorporated by reference into other filings unless expressly stated.
Investor Verification Items
- Verify finalized May and second-quarter 2023 ZTlido gross and net sales in subsequent filings or earnings releases.
- Assess the reconciliation between gross sales and net sales, including discounts, rebates, returns, and other deductions.
- Review subsequent financial statements for profitability, cash flow, liquidity, debt, and any revisions to these preliminary estimates.
- Determine whether the reported sales growth is sustained and whether it translates into improved margins and operating cash generation.